Search

Your search keyword '"Dorronsoro A"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Dorronsoro A" Remove constraint Author: "Dorronsoro A" Database Journals@OVID Remove constraint Database: Journals@OVID
133 results on '"Dorronsoro A"'

Search Results

2. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations

3. Physical activity, mediating factors and risk of colon cancer: insights into adiposity and circulating biomarkers from the EPIC cohort

4. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

6. Hepcidin levels and gastric cancer risk in the EPIC-EurGast study

7. Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study

9. Prediagnostic circulating concentrations of plasma insulin‐like growth factor‐I and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition

10. A Prospective Study of the Immune System Activation Biomarker Neopterin and Colorectal Cancer Risk

11. Circulating Biomarkers of One-Carbon Metabolism in Relation to Renal Cell Carcinoma Incidence and Survival

12. Influence of Dopaminergic System Genetic Variation and Lifestyle Factors on Excessive Alcohol Consumption

14. Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study

15. Vegetable and fruit consumption and the risk of hormone receptor-defined breast cancer in the EPIC cohort1,2

16. Body iron status and gastric cancer risk in the EURGAST study

18. Subtypes of fruit and vegetables, variety in consumption and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition

19. Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort

20. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition1–3

21. Plasma fetuin-A concentration, genetic variation in the AHSG gene and risk of colorectal cancer

22. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition

23. Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study

24. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs

26. Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: Multicentre, prospective cohort study

27. Plasma carotenoids, vitamin C, retinol and tocopherols levels and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutrition: A nested case–control study: Plasma micronutrients and pancreatic cancer risk

28. Meat and fish consumption and the risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition

29. Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk

30. Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort

31. Prediagnostic telomere length and risk of B-cell lymphoma—Results from the EPIC cohort study

32. Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: Results from the EPIC-EURGAST study

33. Circulating 25-Hydroxyvitamin D3 in Relation to Renal Cell Carcinoma Incidence and Survival in the EPIC Cohort

34. Dairy products and risk of hepatocellular carcinoma: The European Prospective Investigation into Cancer and Nutrition

35. Aromatic adducts and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Spanish cohort

36. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer

37. Genome-wide interaction study of smoking and bladder cancer risk

38. Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

39. Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk—Results from the EPIC cohort study

40. Genome-wide association study identifies multiple loci associated with bladder cancer risk

41. Adiposity, mediating biomarkers and risk of colon cancer in the European prospective investigation into cancer and nutrition study

42. Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European prospective investigation into cancer-eurgast cohort

43. Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: Etiological factors or risk markers?

44. Weight change later in life and colon and rectal cancer risk in participants in the EPIC-PANACEA study1-4

45. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study

46. Dietary flavonoid, lignan and antioxidant capacity and risk of hepatocellular carcinoma in the European prospective investigation into cancer and nutrition study

47. Intake of Coffee, Decaffeinated Coffee, or Tea Does Not Affect Risk for Pancreatic Cancer: Results From the European Prospective Investigation into Nutrition and Cancer Study

48. Occupation and risk of lymphoid and myeloid leukaemia in the European Prospective Investigation into Cancer and Nutrition (EPIC)

49. Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort

50. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort

Catalog

Books, media, physical & digital resources